News

Epichaperomes’ that form in some cancer cells might enable selective therapies, according to research from Monica Guzman, Ph.D. Read more

Rohan Ramakrishna, M.D., offers his analysis of the Cancer Moonshot Task Force recommendations. Read more

There has been an overemphasis on the genomic component of precision medicine, according to Mark Rubin, M.D., director of the Englander Institute for Precision Medicine. Read more

Eftychia Apostolou, Ph.D., has won a New Innovator Award from the National Institutes of Health for her research on how cells preserve their identity under normal conditions or alter it during pathogenesis Read more

Richard Furman, M.D., shared insights into CLL treatments at a special session of the 2016 Annual ASH Meeting on Hematologic Malignancies. Read more

Rache Simmons, M.D., discusses a new non-surgical deep-freezing treatment for breast cancer. Read more

While chemotherapy kills the most common type of bladder cancer, urothelial cancer, it also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant, according to Bishoy Faltas and colleagues. Read more

David Rickman, Ph.D., and colleagues have identified a gene that appears to regulate the change from prostate adenocarcinoma to neuroendocrine prostate cancer. Read more

Jeffrey Greenfield, M.D., Ph.D., speaks out about the need for wider - and speedier - use of the FDA compassionate use exception. Read more